Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in dopaminergic neurons

Marie-Amandine Bonte, Flore Gouel, Aurélie Jonneaux, Karim Belarbi, David Devos, Jean-Christophe Devedjian · 2026

Read Long-term inhibition of lysosomal glucocerebrosidase activity promotes GPX4 stability and inhibits ferroptosis in dopaminergic neurons by Marie-Amandine Bonte, Flore Gouel, Aurélie Jonneaux, Karim Belarbi, David Devos, Jean-Christophe Devedjian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13470012.txt.

Description

Bonte and colleagues reported a surprise in 2026: briefly blocking a lysosomal enzyme protected dopamine neurons against one form of cell death, ferroptosis. The enzyme, glucocerebrosidase, is famous because its inherited failure raises Parkinson's risk. The team used a human dopamine cell line and a chemical blocker for ten days. They then challenged the cells with several death triggers, tracking lipid chemistry and a protective enzyme called GPX4.

Only one death route was blunted: cells resisted ferroptosis triggered by RSL3, while other killers worked as usual. The blocker reshaped membrane fats, cutting the ether-linked lipids ferroptosis feeds on, and raised GPX4, the enzyme defusing those fats. Both changes were temporary, gone by twenty days. Most known drugs destroy GPX4 rather than stabilize it, so a stabilizer is a rare lead for shielding neurons in Parkinson's disease.

Catalog record

CREATORMarie-Amandine Bonte, Flore Gouel, Aurélie Jonneaux, Karim Belarbi, David Devos, Jean-Christophe Devedjian
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13470012

Browse the full library · About the Tower of Babel